Overview
Charcot arthropathy, particularly when localized to the calcaneocuboid joint, represents a severe complication of peripheral neuropathy, often seen in patients with diabetes mellitus or other neuropathies. This condition is characterized by progressive bone destruction, joint dislocation, and soft tissue deformities due to a lack of protective sensation. Early recognition and intervention are crucial to prevent irreversible damage and functional impairment. The pathophysiology, epidemiology, clinical presentation, diagnosis, management, and complications of Charcot arthropathy of the calcaneocuboid joint are critical areas of focus for clinicians managing neuropathic patients. Recent advancements in diagnostic tools and treatment modalities are enhancing outcomes but highlight the ongoing need for multidisciplinary care and vigilant monitoring.
Pathophysiology
Acute Charcot Neuroarthropathy (CN) is an end-stage complication primarily affecting individuals with peripheral neuropathy, where the absence of pain sensation leads to repetitive microtrauma and subsequent gross inflammation, redness, and heat in the affected joint [PMID:33827640]. The exact mechanisms underlying the transition from initial trauma to severe bone destruction are still under investigation, but they likely involve a complex interplay of inflammatory cytokines, bone remodeling enzymes, and mechanical stress [PMID:42092303]. Recent literature emphasizes the role of neurogenic inflammation and impaired proprioception in exacerbating these processes [PMID:42092303]. Understanding these mechanisms is pivotal for developing targeted therapeutic interventions aimed at modulating inflammation and stabilizing bone integrity.
Epidemiology
The incidence of Charcot arthropathy, including involvement of the calcaneocuboid joint, has shown a notable upward trend in recent decades, as evidenced by an analysis of 349 papers from 1995 to 2025 [PMID:42092303]. This increase may reflect heightened clinical awareness and research efforts focused on neuropathic complications, particularly in diabetes management. Patients with diabetes mellitus remain the predominant demographic affected, though other causes of peripheral neuropathy, such as alcoholism and hereditary neuropathies, also contribute significantly to the prevalence [PMID:42092303]. The rising trend underscores the need for enhanced preventive strategies and early detection protocols to mitigate the impact of this debilitating condition.
Clinical Presentation
Clinical manifestations of Charcot arthropathy in the calcaneocuboid joint are often subtle initially but progress rapidly if left untreated. Common symptoms include swelling, erythema, and changes in the structural integrity of the foot, which can be more readily identified by experienced clinicians [PMID:33827640]. A notable case described an extensive soft tissue defect measuring 18×6 cm in the weight-bearing zone of the heel, highlighting the severe soft tissue loss that can occur [PMID:33595121]. Patients may also report pain disproportionate to visible injury due to secondary complications like joint instability or superimposed infections. Early recognition by healthcare providers is crucial, as delayed diagnosis often leads to more extensive joint destruction and functional disability.
Diagnosis
Diagnosing Charcot arthropathy, especially in its early stages, remains challenging due to limited awareness among both healthcare professionals and patients/caregivers, frequently resulting in delayed treatment [PMID:33827640]. Traditional clinical examination is supplemented by advanced diagnostic tools such as magnetic resonance imaging (MRI) and three-dimensional imaging techniques, which offer detailed visualization of bone and soft tissue changes [PMID:42092303]. Biomechanical assessments further aid in identifying subtle deformities and joint instability that may not be apparent through physical examination alone. These diagnostic advancements are increasingly being integrated into clinical practice to improve early detection and accurate staging of the disease.
Management
The cornerstone of managing acute Charcot Neuroarthropathy involves immediate and aggressive offloading to prevent further joint destruction. Total contact casting (TCC) remains the gold standard, providing consistent pressure distribution and immobilization necessary to stabilize the affected joint [PMID:33827640]. Beyond conservative measures, a multidisciplinary approach is essential, incorporating podiatry, orthopedics, infectious disease specialists, and wound care teams to address the multifaceted aspects of the condition [PMID:33827640]. Recent research highlights evolving strategies, including surgical interventions and advanced reconstructive techniques. For instance, a case study demonstrated successful treatment of a complex Charcot foot deformity with extensive soft tissue loss using a free tensor fascia lata true-perforator flap (TFLtp), which not only addressed the soft tissue defect but also minimized donor site morbidity [PMID:33595121]. These innovative approaches underscore the potential for improved functional outcomes and quality of life in patients with severe Charcot arthropathy.
Surgical Interventions
In cases where conservative and reconstructive methods fall short, surgical interventions may be necessary to correct severe deformities and manage complications such as osteomyelitis. Advanced reconstructive surgeries, including joint fusions and custom orthotic devices, are increasingly being explored to stabilize joints and restore function [PMID:42092303]. The use of perforator flaps, as seen in the case of the TFLtp, exemplifies the precision and effectiveness of modern reconstructive techniques in managing complex soft tissue defects associated with Charcot arthropathy [PMID:33595121].
Complications
Charcot arthropathy is fraught with potential complications that can significantly impact patient outcomes. Osteomyelitis is a notable complication, often complicating the clinical picture and necessitating aggressive antibiotic therapy and surgical debridement [PMID:33595121]. Joint dislocations and progressive deformities further exacerbate functional impairment, often requiring prolonged rehabilitation and supportive care. Early identification and management of these complications are critical to prevent long-term disability and improve patient prognosis.
Prognosis & Follow-up
The prognosis for patients with Charcot arthropathy varies widely depending on the extent of joint destruction and the timeliness of intervention. Successful reconstructive surgeries, such as those involving advanced flaps, can lead to favorable outcomes, as evidenced by a patient regaining ambulation within five weeks post-surgery [PMID:33595121]. Regular follow-up is essential to monitor healing progress, manage potential complications, and adjust treatment plans as necessary. Multidisciplinary follow-up care, including podiatric evaluations, wound assessments, and psychological support, plays a vital role in ensuring sustained functional recovery and quality of life.
Key Recommendations
References
1 Diacogiorgis D, Perrin BM, Kingsley MIC. Factors impacting the evidence-based assessment, diagnosis and management of Acute Charcot Neuroarthropathy: a systematic review. Journal of foot and ankle research 2021. link 2 Zhou JL, Peng H, Sun F. Bibliometric Analysis of Charcot Arthropathy (1995-2025): Current Status and Emerging Trends. Journal of foot and ankle research 2026. link 3 Tsuihiji K, Daniel BW, Kageyama T, Sakai H, Fuse Y, Tsukuura R et al.. Free tensor fascia lata true-perforator flap transfer for reconstruction of the calcaneal soft tissue defect complicated with osteomyelitis in a patient with alcohol-induced Charcot foot: A case report and literature review. Microsurgery 2021. link
3 papers cited of 4 indexed.